Urology Today.net

Site updated at Friday, 26 June 2015

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



phospho-proteomics1 - acidosis1 - genital tract1 - american society of clinical oncology1 - hereditary renal diseases1 - short-term hormone therapy1 - coffee4 - female incontinence1 - mesonephric duct1 - vagina4 - bladder ulcer1 - kidney tumours1 - female urinary tract1 - inf21 - chronic kidney disease in children1 - vitamin c1 - renal cancer2 - urine test3 - embryonic urothelium1 - urinary ions2 - psa testing3 - ontario health insurance plan1 - chronic hereditary nephritis1 - pyuria1 - lower kidney function2 - carboplatin1 - urinary catheters1 - diets1 - pelvic viscera1 - ectopic pregnancy2 -